Introduction
Congenital aortic stenosis is a rare but clinically significant form of CHD, accounting for approximately 3–6% of all cases. Reference Hoffman and Kaplan1 In patients with critical aortic stenosis, percutaneous aortic balloon valvuloplasty is frequently employed to reduce left ventricular pressure and improve systemic perfusion. However, the development of left ventricular pseudoaneurysm following percutaneous aortic balloon valvuloplasty is exceedingly rare, with only a few paediatric cases reported in the literature. Reference Cassano, Orofino, Tagliente and Arciprete2–Reference Millette, Gangemi, White and Shorofsky5 We present a 1-month-old infant who developed a left ventricular pseudoaneurysm after successful percutaneous aortic balloon valvuloplasty for critical congenital aortic stenosis, managed surgically with excellent outcome.
Case presentation
A 1-month-old female infant was admitted to our paediatric ICU following the diagnosis of critical aortic stenosis at an external centre, where she had presented with progressive respiratory distress. The patient’s personal and family history were unremarkable. She was the only child of healthy, non-consanguineous parents.
On admission, her weight was 3.2 kg (3rd–10th percentile) and length was 52 cm (25th percentile). Vital signs included a heart rate of 164 beats/min, a respiratory rate of 60 breaths/min, and a blood pressure of 55/36 mmHg. Peripheral pulses were weak, and a grade 3/6 systolic murmur was best heard at the cardiac apex. Electrocardiography demonstrated sinus tachycardia with evidence of left ventricular hypertrophy. Chest radiography revealed cardiomegaly and pulmonary oedema.
Transthoracic echocardiography revealed concentric left ventricular hypertrophy with moderately reduced systolic function. The aortic valve was dysplastic and bicuspid in morphology, with an aortic annulus diameter of 6 mm (Z score: –2.05). There was evidence of significant valvular aortic stenosis, accompanied by moderate-to-severe mitral regurgitation and moderate-to-severe tricuspid regurgitation. The estimated right ventricular systolic pressure was markedly elevated at 95 mmHg, consistent with severe pulmonary hypertension secondary to left-sided obstructive and regurgitant lesions.
The patient underwent cardiac catheterisation on the day of admission. Diagnostic angiography was performed via the right femoral artery using a 4F JR4 catheter and a 0.035-inch hydrophilic guidewire. Left ventricular systolic pressure was measured at 125 mmHg, with a peak-to-peak gradient of 60 mmHg across the aortic valve. After crossing the aortic valve, the catheter was positioned in the left ventricular apex, and the hydrophilic wire was exchanged for a 0.021-inch guidewire. Percutaneous aortic balloon valvuloplasty was performed using an OSYPKA VACS II 5/20 mm balloon (Osypka GmbH, Rheinfelden-Herten, Germany). As the post-procedural gradient reduction was suboptimal and no aortic regurgitation was observed, a second dilatation was performed with a 6/20 mm balloon. Following the second inflation, left ventricular pressure decreased to 86 mmHg, and the residual transvalvular gradient was reduced to 16 mmHg. Mild aortic regurgitation was noted.
Post-procedural transthoracic echocardiography revealed no immediate complications. The patient was transferred to the paediatric ICU while intubated and maintained on an epinephrine infusion (0.2 μg/kg/min) for hemodynamic support.
The patient was monitored in the hospital for seven days following percutaneous aortic balloon valvuloplasty. During this period, her clinical condition progressively improved. Follow-up transthoracic echocardiography demonstrated normalisation of left ventricular systolic function. Mitral regurgitation had decreased to a mild-to-moderate degree, while tricuspid regurgitation was mild, and the right ventricular systolic pressure had returned to normal limits. The dysplastic bicuspid aortic valve showed a maximum pressure gradient of 34 mmHg and a mean gradient of 18 mmHg, with mild aortic regurgitation. The assessment revealed no pericardial effusion or post-procedural complications. Given her stable hemodynamic status and improved ventricular function, the patient was discharged on medical therapy with a plan for close outpatient follow-up.
The patient, who was asymptomatic, presented for routine follow-up one week after discharge. Transthoracic echocardiography revealed the presence of a pseudoaneurysm at the left ventricular free wall, accompanied by mild pericardial effusion. The diagnosis was subsequently confirmed by computed tomography imaging (Figure 1).
Multimodality imaging of the left ventricular pseudoaneurysm. ( a ) Fluoroscopic view during percutaneous balloon aortic valvuloplasty demonstrating the balloon across the aortic valve. ( b ) Axial CT angiography showing the large pseudoaneurysm (PSA) arising from the left ventricle (LV). ( c ) Apical four-chamber and ( d ) subcostal echocardiographic views revealing the communication between the LV and the PSA cavity. Ao = Aorta; LA = Left Atrium; LV = Left Ventricle; PSA = Pseudoaneurysm; RV = Right Ventricle.

Figure 1 Long description
The image shows a fluoroscopic view during percutaneous balloon aortic valvuloplasty, demonstrating the balloon positioned across the aortic valve. The axial CT angiography image reveals a large pseudoaneurysm (PSA) arising from the left ventricle (LV). The apical four-chamber and subcostal echocardiographic views show the communication between the LV and the PSA cavity. The labeled parts include the aorta (Ao), left atrium (LA), left ventricle (LV), pseudoaneurysm (PSA), and right ventricle (RV).
As the patient remained hemodynamically stable, surgical intervention was planned. Under cardiopulmonary bypass, a left atriotomy was performed. The mitral valve appeared structurally normal, and the pseudoaneurysm cavity could not be visualised through the atriotomy. Upon elevating the heart from the apex, a 3 × 3 cm perforated area was observed on the posterior surface of the left ventricle, bordered by the circumflex artery, the coronary sinus, and the posterior annulus of the mitral valve. The perforated area was encircled with U-shaped pledgeted Prolene sutures, and the left ventricle rupture was repaired using a xenopericardial patch (Figure 2). The operation was completed without intraoperative complications, and the patient was transferred to the paediatric ICU for post-operative monitoring.
Intraoperative view following the surgical repair. The intraoperative photograph shows the surgical field after successful exclusion of the pseudoaneurysm. The left ventricular wall defect has been repaired using a bovine pericardial patch (view after patch closure), restoring the anatomical integrity of the ventricle.

Figure 2 Long description
The image shows an intraoperative view of a surgical repair. The left ventricular wall defect has been repaired using a bovine pericardial patch, which is visible in the center of the image. The patch is held in place by sutures, and the surrounding tissue appears to be properly aligned. Surgical instruments and retractors are positioned around the repair site, keeping the area open for visualization. The image highlights the successful exclusion of the pseudoaneurysm and the restoration of the anatomical integrity of the ventricle.
Follow-up echocardiography demonstrated no residual defect or pericardial effusion. The patient recovered uneventfully and was discharged on the 7th post-operative day in stable condition. At present, she continues to do well on outpatient follow-up with no evidence of recurrence or need for reintervention.
Discussion
Percutaneous aortic balloon valvuloplasty is a widely accepted first-line therapy for critical congenital aortic stenosis in neonates and infants. The procedure has demonstrated favourable short and mid-term outcomes in improving ventricular function and systemic perfusion. However, although percutaneous aortic balloon valvuloplasty is generally considered safe, it carries the risk of rare but potentially life-threatening complications, such as arrhythmias, cardiac perforation, severe valvular regurgitation, and arterial injury. Reference McElhinney, Lock and Keane6
Left ventricular pseudoaneurysm after percutaneous aortic balloon valvuloplasty is extremely uncommon in paediatric patients, with only a few cases reported in the literature. Reference Cassano, Orofino, Tagliente and Arciprete2–Reference Millette, Gangemi, White and Shorofsky5 In most of these reports, the pseudoaneurysm developed within days to weeks after the procedure, similar to our patient. Cassano et al. Reference Cassano, Orofino, Tagliente and Arciprete2 described a double aneurysm of the left ventricle wall following cardiac perforation during percutaneous aortic balloon valvuloplasty, while Pușca et al. Reference Pusca, Kanter, Fyfe, Kim and Vincent3 reported an aneurysm in a 5-week-old infant without a clear procedural injury. Sánchez Andrés et al. Reference Sánchez Andrés, Insa Albert and Carrasco Moreno4 documented a pseudoaneurysm developing during neonatal percutaneous aortic balloon valvuloplasty, and Millette et al. Reference Millette, Gangemi, White and Shorofsky5 recently reported a preterm neonate who developed a pseudoaneurysm following balloon valvuloplasty. Consistent with these observations, our case highlights the rarity and potential severity of this complication even after an initially uneventful procedure.
The pathophysiological mechanisms underlying left ventricular pseudoaneurysm formation after percutaneous aortic balloon valvuloplasty are not fully understood. Two main hypotheses can be considered. First, direct mechanical trauma to the ventricular wall or apex during catheter or guidewire manipulation may cause myocardial perforation. This is particularly relevant in small infants with thin myocardial walls. Second, increased intraventricular pressure and myocardial stress during or after balloon inflation may lead to tearing or disruption of an already compromised or ischaemic ventricular myocardium. This mechanism is especially important in patients with hypertrophied and poorly compliant ventricles. In our patient, both mechanisms may have contributed. Mechanical injury during catheter exchange or balloon inflation likely acted together with elevated pre-procedural left ventricular pressure and intrinsic myocardial vulnerability.
From a clinical standpoint, left ventricular pseudoaneurysm may remain silent or present with non-specific findings, underscoring the importance of vigilant echocardiographic surveillance after percutaneous aortic balloon valvuloplasty, even in apparently stable patients. Early detection is crucial, as rupture of a left ventricular pseudoaneurysm carries a high risk of mortality. In our case, the pseudoaneurysm was detected incidentally during routine follow-up in an asymptomatic infant, emphasising that a normal immediate post-procedural echocardiogram does not exclude later complications.
Surgical repair remains the treatment of choice for post-percutaneous aortic balloon valvuloplasty left ventricular pseudoaneurysm in infants, as spontaneous resolution is rare and the risk of rupture is significant. In the present case, surgical closure using a xenopericardial patch achieved complete repair without recurrence, consistent with outcomes reported in previous literature.
Conclusion
Left ventricular pseudoaneurysm after percutaneous aortic balloon valvuloplasty in neonates and infants is exceedingly rare, with only a handful of reported cases to date. Our case reinforces the need for close post-procedural follow-up and highlights possible mechanisms, including mechanical injury and elevated left ventricular pressure in vulnerable myocardium. As more cases are reported, the pathophysiology and optimal management of this rare but serious complication will become clearer.
